News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
216 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39122)
2019 (51337)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42567)
2024 (37443)
2025 (33092)
2026 (8525)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
2 (186)
3 (175)
4 (147)
5 (166)
6 (119)
9 (121)
10 (183)
11 (172)
12 (142)
13 (112)
14 (38)
15 (1)
16 (171)
17 (154)
18 (148)
19 (149)
20 (92)
21 (2)
23 (153)
24 (148)
25 (216)
26 (204)
27 (119)
28 (2)
29 (9)
30 (193)
31 (218)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
14
15
16
17
18
19
20
21
23
24
25
26
27
28
29
30
31
Business
The Medicines Company Slashes Hundreds of Jobs in Restructuring
In addition to the layoffs, the company is also looking to divest its Infectious Disease Business.
October 25, 2017
·
2 min read
·
Mark Terry
Drug Development
Aldeyra Therapeutics Presents Evidence for Aldehyde Sequestration as a Potential Therapeutic Approach in Succinic Semialdehyde Dehydrogenase Deficiency at the American Society of Human Genetics 2017 Annual Meeting
Aldeyra Therapeutics presented novel data at the American Society of Human Genetics 2017 Annual Meeting demonstrating that ADX-102 reduced levels of gamma-hydroxybutyrate (GHB) and gamma-aminobutyrate (GABA) in a knockout mouse model of Succinic Semialdehyde Dehydrogenase (SSADH) Deficiency.
October 25, 2017
·
6 min read
Deals
VEXIM Acquired by Stryker in EUR 183M Deal
Stryker picked up controlling interest in Vexim, a French medical device company that specializes in the minimally invasive treatment of vertebral fractures.
October 25, 2017
·
2 min read
·
Alex Keown
FDA
China Approves Tianjin CanSino’s Ebola Vaccine
Tianjin CanSino Biologics announced CFDA approval of its Ebola virus vaccine for China.
October 25, 2017
·
1 min read
Genetown
This Massachusetts Marijuana Biotech is Betting the Farm on One Single Drug
Corbus’ stock popped on the release of topline results from a midstage study involving its lead (and only) clinical drug, anabasum.
October 25, 2017
·
1 min read
Deals
Ablynx Banks $200M IPO in Nasdaq Debut
Ablynx announced the price of its U.S. IPO at $17.50.
October 25, 2017
·
2 min read
·
Mark Terry
Biotech Bay
Investors May be Overlooking This Small, Fast-Growing Bay Area Biotech
You’ve probably heard those advertisements for “the power of protein,” referring to the addition of enzymes to detergent.
October 25, 2017
·
2 min read
·
Mark Terry
Business
Bay Area’s Five Prime Promotes COO to CEO, Effective January 1, 2018
After four months of looking, Five Prime Therapeutics has found its new CEO.
October 25, 2017
·
2 min read
·
Alex Keown
Drug Development
Amgen Discontinues Quest for New CETP Heart Drug
Amgen inherited the drug after acquiring Dezima Pharma in a $1.2 billion deal in 2015.
October 25, 2017
·
2 min read
·
Alex Keown
Business
MacroGenic Scores $900M Checkpoint PD-1 R&D Deal With Incyte
Incyte picked up MGA012 and the exclusive rights to develop the drug worldwide.
October 25, 2017
·
2 min read
·
Alex Keown
1 of 22
Next
